title: Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life.
abstract: BACKGROUND
  Knowledge is scarce concerning the significance of thyroid dysfunction/antibodies during pregnancy in regard to pregnancy complications/later maternal morbidity.
  
  
  OBJECTIVE
  The aim of this study was to evaluate the association between maternal thyroid dysfunction/antibodies during pregnancy and pregnancy complications or later maternal hypertension, diabetes, and thyroid disease.
  
  
  METHODS
  We studied a prospective population-based cohort, Northern Finland Birth Cohort 1986 (NFBC 1986), with follow-up of 20 yr. Medication and hospital discharge records were used to assess maternal morbidity to hypertension, diabetes, and thyroid diseases.
  
  
  METHODS
  The study consisted of mothers of NFBC 1986 with early pregnancy serum samples for thyroid function and antibody analyses (n = 5805). Mothers were grouped and compared according to these test results.
  
  
  METHODS
  We focused on preeclampsia and gestational diabetes during index pregnancy, later maternal hypertension, diabetes, and thyroid disease morbidity and total mortality.
  
  
  RESULTS
  Thyroid dysfunction and antibodies were not associated with pregnancy complications. Overt hypothyroidism was associated with subsequent maternal thyroid disease [hazard ratio (HR) (95% confidence interval), 17.7 (7.8-40.6)] and diabetes [6.0 (2.2-16.4)]. Subclinical hypothyroidism [3.3 (1.6-6.9)], TPO-Ab-positivity [4.2 (2.3-7.4)], and TG-Ab-positivity [3.3 (1.9-6.0)] were also associated with later thyroid disease. No association was found between thyroid dysfunction/antibodies and hypertension or overall mortality.
  
  
  CONCLUSIONS
  Thyroid dysfunction and antibodies during pregnancy seem to predict later thyroid disease. Overt hypothyroidism poses risk of diabetes.
authors.affiliation: Department of Obstetrics and Gynecology, University of Oulu, P.O. Box 5000, 90014 Oulu, Finland.
authors.forename: Tuija
authors.initials: T
authors.lastname: Männistö
authors.forename: Marja
authors.initials: M
authors.lastname: Vääräsmäki
authors.forename: Anneli
authors.initials: A
authors.lastname: Pouta
authors.forename: Anna-Liisa
authors.initials: AL
authors.lastname: Hartikainen
authors.forename: Aimo
authors.initials: A
authors.lastname: Ruokonen
authors.forename: Heljä-Marja
authors.initials: HM
authors.lastname: Surcel
authors.forename: Aini
authors.initials: A
authors.lastname: Bloigu
authors.forename: Marjo-Riitta
authors.initials: MR
authors.lastname: Järvelin
authors.forename: Eila
authors.initials: E
authors.lastname: Suvanto
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001323:Autoantibodies / Q000097:blood*; D015331:Cohort Studies; D003920:Diabetes Mellitus / Q000209:etiology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications; D011446:Prospective Studies; D012044:Regression Analysis; D011795:Surveys and Questionnaires; D013959:Thyroid Diseases / Q000097:blood* / Q000209:etiology*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D001323:Autoantibodies; D014284:Triiodothyronine; D013974:Thyroxine